Standout Papers

Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges 2022 2026 2023 2024150
  1. Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges (2022)
    Eman A. Taha, Joseph Lee et al. Journal of Controlled Release
  2. Extracellular Vesicles: New Classification and Tumor Immunosuppression (2023)
    Eman A. Taha, Yanyin Lu et al. Biology

Immediate Impact

6 by Nobel laureates 5 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression
2024 Standout
1 intermediate paper

Works of Eman A. Taha being referenced

Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges
2022 Standout
Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion
2019

Author Peers

Author Last Decade Papers Cites
Eman A. Taha 561 196 94 14 671
Katrin Tiemann 688 181 76 15 826
Hassan Dana 536 197 97 15 738
Bai‐Liang He 619 273 128 21 810
Pratima Basak 403 138 90 21 629
Uwe Galli 612 363 70 11 796
Kelly Hodge 482 168 71 15 603
Liang Gao 468 218 160 23 672
Josefa Carrión-Navarro 517 369 60 18 684
Shyam Bandari 708 330 91 17 831
David Peers 569 120 123 8 804

All Works

Loading papers...

Rankless by CCL
2026